Character Biosciences

Jersey City, NJ · Founded 2018 · Privately Held (backing)

Developer of precision medicine designed to transform drug development for progressive, polygenic diseases. Character Biosciences is based in Jersey City, NJ and was founded in 2018. It was valued at $203 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $137 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Sep 2025.

PMV mark · valuation
$203.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$136.9M
Last round
Early Stage VC
Sep 2025
What is Character Biosciences worth?
$203.0MPrivateMarketView mark · Oct 2026

Valued at $203.0M at its later-stage round, Sep 2025. Nothing has traded since.

Free account
More of Character Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch Character Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Character Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Sep 2025Early Stage VC$8.9M▮
Mar 2025Early Stage VC$48.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Character Biosciences valuation

Character Biosciences was valued at $203 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Character Biosciences raised?

Character Biosciences has raised $137 million in total; 2 of its rounds are on record. The largest on record was an $8.9 million early-stage round in Sep 2025.

Character Biosciences has filed 2 Form Ds with the SEC, most recently in Sep 2025 ($8.9 million sold to 4 investors).

How Character Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Character Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Character Biosciences

What is Character Biosciences worth?
Character Biosciences is valued at $203.0M as of Oct 2026. Valued at $203.0M at its later-stage round, Sep 2025. Nothing has traded since.
How much has Character Biosciences raised?
Character Biosciences has raised $136.9M in total funding across 2 recorded rounds.
When did Character Biosciences last raise?
Character Biosciences last raised in Sep 2025 (Early Stage VC), raising $8.9M.